Abstract
The O-N intramolecular acyl migration, also named as an acyl shift or acyl transfer reaction, is well-known in organic and peptide chemistry as a simple rearrangement which proceeds under very mild aqueous conditions. Despite a long history with this reaction, its application in medicinal chemistry has only lately been proposed. In the last decade, this reaction has been intensively studied and several applications of this rearrangement in medicinal chemistry have appeared. O-N Intramolecular acyl migration has been employed in “no auxiliary, no byproduct” prodrug strategies (prodrugs of paclitaxel and other taxoids, prodrugs of HIV protease inhibitors), for the synthesis of peptides containing difficult sequences via “O-acyl isopeptide method”, including Alzheimers disease related amyloid β peptide (Aβ) 1-42, and in the design of pH-, photo- or enzyme-triggered click peptides, as a potential powerful tool for identifying the pathological functions of amyloid β peptides in Alzheimers disease. This review summarized recent advances in the application of O-N intramolecular acyl migration with special focus on medicinal chemistry.
Keywords: O-N Intramolecular acyl migration, O-N intramolecular acyl shift, O-N intramolecular acyl transfer, HIV protease inhibitor prodrugs, paclitaxel prodrugs, O-acyl isopeptide method, depsipeptide, Alzheimer's disease
Current Medicinal Chemistry
Title: Application of the O-N Intramolecular Acyl Migration Reaction in Medicinal Chemistry
Volume: 14 Issue: 26
Author(s): Mariusz Skwarczynski and Yoshiaki Kiso
Affiliation:
Keywords: O-N Intramolecular acyl migration, O-N intramolecular acyl shift, O-N intramolecular acyl transfer, HIV protease inhibitor prodrugs, paclitaxel prodrugs, O-acyl isopeptide method, depsipeptide, Alzheimer's disease
Abstract: The O-N intramolecular acyl migration, also named as an acyl shift or acyl transfer reaction, is well-known in organic and peptide chemistry as a simple rearrangement which proceeds under very mild aqueous conditions. Despite a long history with this reaction, its application in medicinal chemistry has only lately been proposed. In the last decade, this reaction has been intensively studied and several applications of this rearrangement in medicinal chemistry have appeared. O-N Intramolecular acyl migration has been employed in “no auxiliary, no byproduct” prodrug strategies (prodrugs of paclitaxel and other taxoids, prodrugs of HIV protease inhibitors), for the synthesis of peptides containing difficult sequences via “O-acyl isopeptide method”, including Alzheimers disease related amyloid β peptide (Aβ) 1-42, and in the design of pH-, photo- or enzyme-triggered click peptides, as a potential powerful tool for identifying the pathological functions of amyloid β peptides in Alzheimers disease. This review summarized recent advances in the application of O-N intramolecular acyl migration with special focus on medicinal chemistry.
Export Options
About this article
Cite this article as:
Skwarczynski Mariusz and Kiso Yoshiaki, Application of the O-N Intramolecular Acyl Migration Reaction in Medicinal Chemistry, Current Medicinal Chemistry 2007; 14 (26) . https://dx.doi.org/10.2174/092986707782360123
DOI https://dx.doi.org/10.2174/092986707782360123 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Informal Caregiving for People with Dementia and Women’s Health: A
Gender-based Assessment of Studies on Resilience
Current Women`s Health Reviews NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer's Disease
Current Drug Discovery Technologies The Endocannabinoid System: A Promising Target for the Management of Type 2 Diabetes
Current Protein & Peptide Science Concentration-Dependent Bimodal Effect of Specific 18 kDa Translocator Protein (TSPO) Ligands on Cell Death Processes Induced by Ammonium Chloride: Potential Implications for Neuropathological Effects Due to Hyperammonemia
CNS & Neurological Disorders - Drug Targets Update on the Medical Treatment of Allergic Rhinitis
Inflammation & Allergy - Drug Targets (Discontinued) Synthesis and Structure-Activity Relationship Studies of <i>N</i>-monosubstituted Aroylthioureas as Urease Inhibitors
Medicinal Chemistry Mechanisms of Developing Post-Traumatic Stress Disorder: New Targets for Drug Development and Other Potential Interventions
CNS & Neurological Disorders - Drug Targets Mental Health of Children of Immigrants and Ethnic Minorities in Europe
Adolescent Psychiatry Mitochondrial Genomics and Proteomics
Current Genomics Peripheral Corticotropin Releasing Factor Signaling Inhibits Gastric Emptying: Mechanisms of Action and Role in Stress-related Gastric Alterations of Motor Function
Current Pharmaceutical Design Proteasome Modulator 9 and Depression in Type 2 Diabetes
Current Medicinal Chemistry Computational Studies on Translocator Protein (TSPO) and its Ligands
Current Topics in Medicinal Chemistry The Utilization of the Monte Carlo Technique for Rational Drug Discovery
Combinatorial Chemistry & High Throughput Screening Competitive Interaction Between Plasma Omega-3 Fatty Acids and Arachidonic Acid is Related to Down-Regulation of A Signaling Mediator
Medicinal Chemistry Fitness or Fatness: The Debate Continues for AMP-Activated Protein Kinase in Heart Function
Current Cardiology Reviews BMI1 Regulation of Self-Renewal and Multipotency in Human Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Invertebrate FMRFamide Related Peptides
Protein & Peptide Letters Antibodies Against Complement System in SLE and their Potential Diagnostic Utility
Current Rheumatology Reviews Clinical Uses of Low – Dose Ketamine in Patients Undergoing Surgery
Current Drug Targets The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations
Current Cancer Drug Targets